42 results about "MENIERE DISEASE" patented technology

The invention discloses a Chinese medicinal composition for treating meniere disease and a preparation method of the Chinese medicinal composition. The Chinese medicinal composition comprises the following components in parts by weight: 25-45 parts of medcinal evodia fruits, 25-45 parts of cassia twig, 20-40 parts of white paeony roots, 20-40 parts of prepared common monkshood daughter roots, 15-30 parts of bighead atractylodes rhizomes, 15-30 parts of poria cocos, 15-30 parts of dark plum fruits, 8-20 parts of immature bitter oranges, 6-18 parts of kudzuvine roots, 3-12 parts of nacre, 6-15 parts of Chinese-dates, 5-15 parts of szechuan lovage rhizomes, 4-12 parts of tangerine peels and 2-10 parts of honey-fried licorice root. The Chinese medicinal composition can be prepared into any clinically acceptable medicine preparation by a conventional preparation method of Chinese medicines. The Chinese medicinal composition has functions of soothing the nerves and arresting the convulsion, warming the channels to smoothen the pulse and soothing the nerves and developing the intelligent. The clinical curative effect shows that the Chinese medicinal composition is precise and reliable in curative effect of the meniere disease, and safe in clinical application, and has a function of treating both manifestation and root cause of disease and no side toxic or side effects.

The invention discloses a traditional Chinese preparation for treating Menieres disease, and the traditional Chinese preparation comprises the following components in parts by weight: 1-10 parts of hairyvein agrimony, 1-5 parts of cassia seed, 0-8 parts of the root of red-rooted salvia, 0-6 parts of Tuckahoe, 0-4 parts of rhizoma gastrodiae and 0-3 parts of bighead atractylodes rhizome. In the traditional Chinese preparation provided by the invention, the traditional Chinese medicines such as the hairyvein agrimony, the cassia seed and the other traditional Chinese medicines are compatible and are decocted into a decoction for oral administration. Thus, all the clinical symptoms such as dizziness, nausea, vomit, nystagmus and the like of patients disappear, and no patient recurs through a follow-up visit for three years. The traditional Chinese preparation for treating the Menieres disease disclosed by the invention has the advantages of simple preparation method, low expense, good treatment effects, no toxic or side effect, no recurrence and no rebound.

The invention relates to a drug for treating Meniere disease, which is a capsule product prepared by the following steps of evenly mixing purified pinellia tuber, stir-fried liquoric root, red ochre and magnetite with membranous milkvetch root, inula flower, tangerine peel, bitter orange, bamboo shavings, Indian buead, chrysanthemum, barbary wolfberry fruit, kudzuvine root and oriental waterplantain rhizome, adding water for decoction, then concentrating into a thick paste, drying, smashing, packaging into capsules and carrying out sterilization and disinfection. The drug has the effects of benefiting qi, regulating stomach, dissipating phlegm, lowering adverse qi, suppressing hyperactive liver and calming wind and is characterized by actual efficacy, rapidness, convenience and safe administration for treating the Meniere disease. The clinical observation shows that the effective rate of the drug is 96.0%.

An application of the yellowsteam milkwort as Chinese-medicinal materials in prepairng the medicines to treat Meniere's disease is disclosed. Its decoction or water-soluble component has also the function of promoting blood circulation and improving immunity.

The invention discloses a traditional Chinese medicine for treating a meniere disease. The traditional Chinese medicine is prepared from the following medicinal materials in parts by weight: aerides falcata, rehmannia glutinosa, fructus corni, barbary wolfberry fruit, uncaria rhynchophylla, salsola collina, tribulus terrestris, wolfiporia cocos, polyporus umbellatus, semen ziziphi spinosae, cratoneuron filicinum, ginseng flowers, ginseng seeds, phellodendron amurense, concha margaritiferallsta, arundina graminifolia, magnetite, ossa draconis, concha ostreae, gastrodia elata, chrysanthemum, radix paeoniae alba, tiger lily, caulis bambusae in taeniam, rhizoma pinellinae praeparata, prunella vulgaris, roasted fructus aurantii immaturus, rhizoma acori graminei, rhizoma cyperi, angelica sinensis, ligusticum wallichii, radix achyranthis bidentatae, rhizoma alismatis, gentiana scabra bge, silkworm excrement, Chinese parsnip root, glossy privet fruit, fineleaf schizonepeta herb, rhizoma cimicifugae, radix puerariae, codonopsis pilosula, astragalus membranaceus, husked sorghum, fried semen coicis, roasted radix polygalae, lotus leaf base, fried fructus aurantii, radix bupleuri, concha haliotidis, the seed coat of black soybeans and ruddle. The clinical experiment proves that the traditional Chinese medicine can be used for safely and effectively treating the meniere disease.

The invention relates to a placenta immunity adjusting medicine capsule with each medical dose unit containing 1/50 to 1/10000mL placenta tissue fluid. A poultry egg serves as an attachment agent and is added with the placenta tissue fluid for full agitation. The solution is dried and then crushed into powder which is then put into capsules. The medicine capsule can stimulate the immunity action, thus achieving the aim of health care and curing and preventing diseases. As the amount of the effective ingredients is small, no adverse drug reaction is occurred. Seen through the treatment to prostatomegaly urinary retention, nephritis, epilepsy, inflammatory aches, Meniere disease, etc., the capsule achieves good result.

The invention relates to gastrodin in-situ gel for treating inner ear diseases, wherein the inner ear diseases include meniere disease, sudden deafness and vestibular neuronitis. The gastrodin in-situ gel is characterized by being composed of the components in parts by weight: 10-20 parts of gastrodin, 0.3-0.8 part of ion-activated gel material, 0.5-2 parts of transfer accelerant, 0.02-0.05 part of preservative and 100 parts of purified water. The in-situ gel provided by the invention is suitable for intranasal administration and capable of remarkably increasing the efficiency for transferring gastrodin from the auditory tube to the inner ear and greatly increasing the local bioavailability of gastrodin to the inner ear.

The invention belongs to the field of pharmacies and particularly relates to a drug for treating a meniere disease. The composition for treating the meniere disease comprises the following components in parts by weight: 30-90 parts of raw oyster shell, 5-15 parts of processed pinellia ternate, 5-15 parts of dried orange peel, 6-18 parts of poria cocos, 10-30 parts of bighead atractylodes rhizome, 15-45 parts of rhizoma alismatis, 8-23 parts of uncaria, 10-30 parts of spina date seed, 8-23 parts of tuber fleeceflower stem and 5-14 parts of gastrodia elata. A preparation method of a preparation of the composition comprises the steps of 1, smashing and mixing the components except the raw oyster shell and the uncaria; 2, decocting the raw oyster shell; and 3, adding the mixture obtained in the step 1 into the decoction liquid obtained in the step 2, decocting for 15-20 minutes through taking a marmite as a decoction vessel, finally adding the uncaria in the formula ratio, decocting for 10-15 minutes and obtaining the preparation. The preparation is high in bioavailability and is capable of effectively controlling and reducing the symptom of severe dizziness of patients; for the situations of mild dizziness, tinnitus, nausea and vomiting, the preparation has short onset time and is capable of completely removing the symptoms; and the relapse rate is obviously reduced in an one-year follow-up visit and no adverse reaction is produced.

The invention discloses gel preparation containing gentamycin and poloxamer. The gel preparation contains aminoglycoside antibiotics and poloxamer. In the pharmaceutical composition of the medicines, poloxamer accounts for approximately 21% to 40% of the weight of the composition. Preferably, poloxamer accounts for approximately 23% to 28% of the weight of the composition, and optimally, poloxamer accounts for approximately 25%. The gel preparation can be used for treating Meniere diseases.

The invention discloses a hairyvein agrimonia herb preparation for treating Menieres disease and a preparation method thereof, which belong to the technical field of medicines. Menieres disease is globally recognized as a difficult and baffling disease for its complex pathogenesis, long course of disease and repeated outbreak. The hairyvein agrimonia herb preparation for treating Menieres disease of the invention is prepared from hairyvein agrimonia herb fine powder by modern pharmaceutical technology, so the process is scientific and the quality is controllable. When the hairyvein agrimonia herb preparation is used in the treatment of Menieres disease, the treatment effect is exact, the side effects are fewer, the cure rate is high, relapse is avoided and clinical medicament administration is convenient.

The invention relates to a traditional Chinese medicine for treating meniere disease and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-20 parts of gastrodia elata, 3-8 parts of schisandra chinensis, 12-17 parts of spina date seed, 12-19 parts of Chinese yam, 4-9 parts of agrimonia pilosa ledeb, 8-12 parts of rhizoma arisaematis, 3-8 parts of pinellia ternata, 11-18 parts of poria cocos, 10-19 parts of rhizoma atractylodis macrocephalae, 15-20 parts of rhizoma alismatis, 4-9 parts of cassia twig, 3-8 parts of polyporus umbellatus, 11-15 parts of ginkgo, 5-10 parts of mulberry, 4-10 parts of swimming bladder, 9-12 parts of golden cicada and 3-8 parts of earthworm. The traditional Chinese medicinal materials are reasonably combined and complementary with one another, and the traditional Chinese medicine is capable of effectively relieving and treating dizziness, deafness, tinnitus, ear fullness and other symptoms caused by the meniere disease, playing a long-term prevention effect and reducing relapse.

The invention belongs to the field of traditional Chinese medicine preparations, in particular relates to a traditional Chinese medicine preparation for treating Meniere disease, which is characterized by being prepared from the following raw materials in parts by weight: 2 parts of tuber pinellia, 3 parts of gastrodia tuber, 3 parts of rhizoma alismatis, 2 parts of chuanxiong rhizome, 2 parts of angelica, 3 parts of motherwort, 3 parts of tuckahoe and 4 parts of kudzu root. The traditional Chinese medicine preparation provided by the invention is developed by long-term clinical practice on the basis of traditional Chinese medicine diagnosis and treatment, has the functions of strengthening the spleen, eliminating dampness, removing phlegm and relieving dizziness by combining all raw medicines, has an exact effect on treating the Meniere disease, has the advantages of high effect taking speed, high cure rate, short course of treatment, no toxic side effects and the like, and is convenient to take.

The invention discloses a medicine for preventing and treating motion sickness and Meniere disease and application of mozavaptan in preparation of medicines for preventing and treating motion sickness and Meniere disease. The medicine is prepared from mozavaptan with an effective dosage for preventing and treating motion sickness and a pharmaceutically acceptable carrier. By adopting the mode, the medicine has an effective reference effect in the aspects of prevention and treatment of motion sickness and Meniere disease, further achieves an effective medicinal effect, and has a relatively small side effect.

The invention relates to a traditional Chinese medicine health-care food for effectively treating meniere disease. The traditional Chinese medicine health-care food is prepared from the following materials in parts by weight: 5 parts of plum blossom, 6 parts of sweet-scented osmanthus, 8 parts of lobed kudzuvine seed, 3 parts of mountain leek, 1 part of cynomorium songaricum, and 20 parts of glutinous rice flour. A test meal experiment proves that the health-care food disclosed by the invention can safely and effectively release and treat the meniere disease after being eaten for a long period of time.

The invention relates to the field of medicines, and specifically relates to applications taking one or more ginkgo terpene lactone compounds or pharmaceutically acceptable salt, ester, hydrate and solvate thereof, or any crystal forms, racemate and metabolite thereof, or a mixture thereof as effective components in the preparation of drugs and health products for preventing and/or treating vertigo. During a process that the provided ginkgo terpene lactone is used for preventing and/or treating posterior circulation ischemic rats and meniere's disease rats, vertigo symptoms can be significantly improved; a synergistic effect occurs when the provided ginkgo terpene lactone composition is taken as the drugs for preventing and/or treating the vertigo; effects of the provided ginkgo terpene lactone for preparing the drugs for preventing and/or treating the vertigo are better than that of a ginkgo leaf extract product; and the ginkgo terpene lactone can significantly improve the conditionsof vascular vertigo and migraine vertigo patients in clinical observation tests, has no adverse reaction during medication, and is high in patient tolerance and good in medication compliance.

The invention discloses a preparation method of rhizoma alismatis soup. The preparation method comprises the following steps: a, selecting preparation instruments and reagents; b, processing rhizoma alismatis decoction pieces; c, processing rhizoma atractylodis macrocephalae decoction pieces; and step d, preparing the rhizoma alismatis soup. In the preparation method, Sichuan rhizoma alismatis and Anhui rhizoma atractylodis macrocephalaeare selected, and the rhizoma alismatis is soaked with water for 12 hours, moistened for more than 8 hours until the rhizoma alismatis is thoroughly penetrated, cut into a specification of 3mm, and dried at 60 DEG C; and the cutting method of the rhizoma atractylodis macrocephalae medicinal material comprises the following steps: soaking the rhizoma atractylodis macrocephalae in water for 32 hours, moistening for more than 8 hours until the rhizoma atractylodis macrocephalae is thoroughly filled, cutting into the specification of 3mm, and drying at 60 DEG C. The preparation process is standard, and the prepared rhizoma alismatis soup has consistent curative effects, has the effects of tonifying spleen, inducing diuresis and removing fluid retention, is mainly used for treating fluid retention, no rising of clear yang under the heart, rising of turbid yin, dizziness, white and greasy tongue coating and slippery pulse, and is mainly used for treating meniere disease, cervical vertigo, hypertension, insufficient vertebrobasilar artery blood supply, hyperlipidemia and other diseases clinically.

The invention relates to a traditional Chinese medicine composition for treating meniere disease as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition comprises the following raw materials of stir-baked caulis banbusae in teaniam with ginger juice, rhizoma pinelliae preparata, pearl shell, chrysanthemums, poria, adenophora stricta, immature orange fruits, white peony roots, radix puerariae, radix salviae miltiorrhizae, Chinese wolfberry fruits, cornus officinalis sieb et zucc, ramuli umcariae cum uncis, magnet, bighead atractylodes rhizomes, herbs of ajuga becumbens thunb, radix rehmanniae, plantain seeds, radix achyranthis bidentatae, rhizoma gastrodiae, Chinese magnoliavine fruits, rhizoma alismatis,motherwort and licorice roots. The traditional Chinese medicine composition for treating meniere disease has the advantages that scientific and reasonable compatibility is realized, the medicines complement each other, liver, spleen and kidney diseases can be treated, and the traditional Chinese medicine composition has the effects of clearing heat, removing toxicity, eliminating dampness and phlegm, lowering the adverse flow of qi, preventing vomiting, regulating qi-flowing for strengthening spleen, and simultaneously treating principal and subordinate symptoms, is good in treatment effect, takes effect quickly, is free from side effect, can be used for treating staggers caused by various reasons, and has notable treatment effect on meniere disease.

The invention discloses a medicine for preventing and treating motion sickness and meniere disease and medical use of an atrial natriuretic peptide. The medicine comprises an effective amount of the atrial natriuretic peptide for preventing and treating the motion sickness and a pharmaceutically acceptable carrier. In the above mode, the medicine can play an effective reference role in the prevention and treatment of the motion sickness and meniere disease, and further can play an effective drug role.

The invention relates to a traditional Chinese medicine liquid preparation for treating Meniere disease, wherein the production raw materials comprise the following traditional Chinese medicines by mass: 8 parts of gentiana scabra bunge, 10 parts of chenxianghao, 8 parts of heartleaf houttuynia herb, 7 parts of ground beetle, 12 parts of plantaginis semen, 10 parts of rhizoma pinelliae, 10 parts of gastrodia elata, 9 parts of pericarpium citri reticulatae, 10 parts of agastache rugosa, 8 parts of tuckahoe, 10 parts of concha haliotidis, 10 parts of achyranthes bidentata, 10 parts of taxillus sutchuenensis (lecomte) danser, 12 parts of ophiopogon japonicus, 10 parts of rehmannia glutinosa libosch, 10 parts of dragon's bone, and 5 parts of licorice root. The production method comprises: infiltrating the traditional Chinese medicine raw materials with water, boiling for 30 min, taking the drug liquid, and bottling to obtain the product.

The invention discloses an application of digoxin in medicines for preventing and treating motion sickness and meniere disease, an experimental animal adopted in an effect experiment is a Sprague-Dawley (SD) rat with the weight of 200-220 g, the rat is female and adaptive to be fed for 3 days, then an experiment of inducing motion sickness and meniere disease two-dizziness model through rotational stimulation is performed, and conditional taste aversion is taken as the model; digoxin anti-dizziness experiment is performed, and the change of the drinking amount of the rat to the 0.15% saccharin sodium solution two days after rotation stimulation is detected by taking the conditional taste aversion induced by rotation stimulation as a model; and digoxin is applied to antagonize the action of rotation stimulation and increased arginine vasopressin and halocorticoid aldosterone on the inner ear, antagonize excessive lymph generation in the inner ear, reduce vestibular stimulation sensitivity, inhibit the occurrence of motion sickness and inhibit the progress of the meniere disease.

The invention relates to the technical field of medical treatment, in particular to a drug for preventing and treating a motion sickness and a meniere disease and a medical application of spirolactone. The drug comprises an effective dose of spirolactone for preventing and treating the motion sickness, wherein the drug is in a dose unit form; and the dosage of the spirolactone is 20-60 mg when anadult is injected with the spirolactone in a single dose. The drug can have an effective reference function in preventing and treating the motion sickness and the meniere disease, thereby further playing an effective drug role.

The invention discloses a pearl powder-cantharis dizzy pain patch, which is prepared from the following raw materials in parts by weight: 105-117 parts of pearl powder, 127-140 parts of cantharis, 152-168 parts of borneol, 237-262 parts of Chinese honeylocust spine, 254-280 parts of camphor, 355-393 parts of castor bean, 406-449 parts of fructus gardenia and 1,030-1,140 parts of honey. The total effective rate of the pearl powder-cantharis dizzy pain patch on dizziness caused by diseases such as a Meniere disease and the like is over 94 percent, being higher than those of other medicaments used clinically, and contributes to preventing relapse. The pearl powder-cantharis dizzy pain patch is a Chinese medicinal external patch, has the effects of completely avoiding carryover effects such as drowsiness, headache, hypodynamia, loss of spirit and the like occurring in the treatment processes of chemical medicaments for treating similar disease symptoms as well as the untoward effect of liver and kidney injuries, and is convenient to use.

Provided are articles of manufacture, compositions and methods for prophylaxis and/or therapy for disorders involving dizziness and/or vertigo. The articles of manufacture and compositions contain lamotrigine and/or bupropion and pharmaceutically acceptable salts thereof. The compositions include pharmaceutical compositions which are intended to alleviate dizziness and/or vertigo. In certain aspects the disclosure includes articles of manufacture and kits which include printed material which provides an indication that the articles or compositions are intended to be used for prophylaxis and/or therapy of Meniere's disease or a symptom thereof.

The invention relates to a medicine capsule used for adjusting the plasma immunity. Each of the medicine dose unit contains 1 to 500mg plasma protein. The medicine takes a poultry egg as an adhesive agent. The fresh plasma is added into the poultry egg for full agitation, then dried and crushed into powder, and then the powder is added into the capsules. The medicine capsule can stimulate the immunity action, thus achieving the aim of health care and curing and preventing diseases. As the amount of the effective ingredients is small, no adverse drug reaction is occurred. Seen through the treatment to body aches, bronchial asthma, epilepsy, inflammatory aches, Meniere disease, etc., the capsule achieves good result.

The invention discloses a Chinese medicine capsule for treating dizziness and a preparation method of the Chinese medicine capsule. The Chinese medicine capsule is prepared from the following raw materials: gaultheria leucocarpa (radix gaultheriae), zeolite powder and grease magnesium. The preparation method comprises the following steps: backflowing gaultheria leucocarpa at 70-80 DEG C to extract for three times by using 4 times of 30% ethanol, soaking for 24 hours and subsequently backflowing to extract for 1.5 hours for the first time, backflowing to extract for 2 hours for the second time, backflowing for 1.5 hours for the third time, combining the extracted solutions, recycling ethanol, depressurizing and concentrating to be extract with the relative density of 1.30-1.38 (50-60 DEG C), drying, grinding into powder, adding lubricating substances, talcum powder and grease magnesium, uniformly mixing and filling. The Chinese medicine capsule can expel damp to remove stasis and activate the blood to remove stasis, is mainly used for treating alternating dizziness and phlegm stagnation, has a definite effect on dizziness of different symptoms, and is particularly remarkable in treating phlegm stagnation alternating type meniere disease, and is applicable to treatment on dizziness and phlegm stagnation alternating diseases.